Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026

This is a routine earnings call notification with no new financial data disclosed.

What the company is saying

Health Catalyst, Inc. is informing investors that its second quarter 2026 operating results will be released after market close on August 6, 2026. The company provides detailed instructions for accessing the conference call and webcast, including dial-in numbers, conference ID, and replay availability for approximately 90 days. The announcement highlights Health Catalyst's positioning as a healthcare intelligence company, emphasizing its proprietary AI-driven technology and domain expertise. A $2.8 billion figure in documented outcomes is cited to underscore impact, but no timeframe or supporting detail is given. The tone is neutral and factual, with the only promotional language confined to the company description. No forward-looking statements, guidance, or financial projections are included.

What the data suggests

The only numerical disclosure is the $2.8 billion in documented outcomes attributed to Health Catalyst's technology and expertise. No financial results, revenue, profit, margins, or cash flow figures are provided in this announcement. There is no context for the $2.8 billion figure, such as the period it covers or how it was calculated. No guidance or comparable period data is offered, making it impossible to assess financial trajectory or performance. The data quality is insufficient for financial analysis, as all material results are deferred to the upcoming earnings release. An independent analyst would conclude that this announcement is purely logistical and contains no actionable financial information.

Analysis

The announcement is a standard notification of an upcoming earnings release and conference call, with no financial results, guidance, or forward-looking projections disclosed. The only promotional language is in the company description, which references $2.8 billion in documented outcomes but does not provide context or evidence for this figure. All other claims are factual and relate to logistics for the earnings call. There is no mention of capital outlays, new initiatives, or long-term projections. The gap between narrative and evidence is minimal, as the release does not attempt to frame any future benefits or make aspirational claims. The tone is neutral and appropriate for the content.

Risk flags

• ●Disclosure risk is high because no financial results, guidance, or performance metrics are included, leaving investors with no basis for analysis until the actual earnings release.
• ●The $2.8 billion in documented outcomes is presented without time frame, methodology, or independent verification, making its relevance and reliability unclear.
• ●Operational and financial risks cannot be assessed from this announcement due to the absence of any substantive disclosures beyond call logistics.

Bottom line

This announcement serves only to notify investors of the upcoming second quarter 2026 results release and the logistics for accessing the call. No financial data, guidance, or forward-looking statements are provided, so there is no basis for evaluating Health Catalyst, Inc.'s financial health or outlook from this release. The $2.8 billion in documented outcomes is the only quantitative claim, but without context, it does not inform investment decisions. Investors will need to wait for the actual earnings release to obtain actionable information. The most important takeaway is that this announcement is purely procedural and not actionable for investment decisions.

Announcement summary

(NASDAQ:HCAT) Health Catalyst, Inc. will release its second quarter 2026 operating results on Thursday, August 6, 2026, after market close. The company will host a conference call to review the results at 5:00 pm ET on the same day. Health Catalyst, Inc. is a healthcare intelligence company that accelerates measurable improvement for health systems across cost, clinical, and consumer performance. Health Catalyst is backed by deep domain expertise, proprietary AI-driven technology, and $2.8 billion in documented outcomes.

Disagree with this article?